AQST ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥11/3/2026
EPSå®çžŸïŒUSDïŒ-0.13
売äžé«å®çžŸïŒUSDïŒ7.56M
Aquestive Therapeutics Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Aquestive Therapeutics Inc ã®æ±ºç®å ±åæžã次å Aquestive Therapeutics Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãAquestive Therapeutics Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Aquestive Therapeutics Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
AQST 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
AQST FY2025 決ç®
EPS (å幎åææ¯)-0.78-53.97%
売äžé« (å幎åææ¯)44.55M-22.61%
Aquestive Therapeutics IncïŒAQSTïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 11/3/2026 | 09/2026 | -0.13/-0.12 | 7.56M/11.02M | -13.55% | -31.41% |
| 8/11/2026 | 06/2026 | -0.18/-0.10 | 13.82M/11.42M | -77.03% | 21.03% |
| 5/13/2026 | 03/2026 | -0.07/-0.14 | 14.45M/10.90M | 52.09% | 32.58% |
| 3/4/2026 | 12/2025 | -0.26/-0.13 | 13.02M/13.28M | -96.88% | -2.03% |
| 11/5/2025 | 09/2025 | -0.14/-0.13 | 12.81M/12.94M | -5.42% | -1.06% |
| 8/11/2025 | 06/2025 | -0.14/-0.17 | 10.00M/11.32M | 18.97% | -11.63% |
| 5/12/2025 | 03/2025 | -0.24/-0.17 | 8.72M/12.23M | -41.24% | -28.70% |
| 3/5/2025 | 12/2024 | -0.19/-0.14 | 11.87M/13.08M | -37.75% | -9.30% |
Aquestive Therapeutics Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ã¢ã±ã¹ãã£ãã»ã»ã©ãã¥ãŒãã£ã¯ã¹ïŒAQSTïŒ2026幎第3ååæ決ç®èª¬æäŒïŒAnaphylmã®FDA審æ»ãšæå è³é9,030äžãã«
ã¢ã±ã¹ãã£ãã»ã»ã©ãã¥ãŒãã£ã¯ã¹ã®2026幎第3ååæ決ç®èª¬æäŒïŒAnaphylmã¯2027幎3æã®FDAïŒç±³é£åå»è¬åå±ïŒã®æ±ºå®ãåŸ
ã£ãŠãããçŸéæ®é«ã¯9,030äžãã«ã«éããæ¥çžŸäºæ³ïŒã¬ã€ãã³ã¹ïŒã¯ç¶æãããŸããã